TIME (Eastern)
7:30 AM
On-site registration open / Exhibit Halls Open (Breakfast available in Exhibit Hall 1 & 2)
‍
8:30 - 9:30 AM
Welcome & Opening Ceremony

Welcome and Introduction
Julie Birkofer, Senior Vice President, Head of North America - PPTA

Welcoming Remarks
Anita Brikman, President & CEO - PPTA

Keynote Speech
Patrick James Lynch, Founder & CEO - Believe Limited

9:30 - 10:15 AM 
Networking Break in Exhibit Hall 1 & 2
An opportunity for attendees to network with meeting participants, speakers, and sponsors.

10:15 - 10:45 AM
SESSION 1: Hereditary Angioedema: The Role of Patient Advocacy Organizations in Attaining Access to Therapy and Improving Patient Quality of Life
People suffering from hereditary angioedema are represented by the US HAE Association and HAE International. These teams of highly motivated advocates focus on making a positive and measurable impact on quality of life by providing an extensive array of programs, educational resources, and hands-on assistance that help people with HAE win access to and reimbursement for the HAE therapy prescribed by their physician.

Speaker: 
Tony Castaldo, CEO and Chairman of the Board - US HAE Association
‍
10:45 AM - 11:45 AM
SESSION 2: Understanding the Alpha-1 Patient Journey: From Pediatric to Adolescence and Adulthood
Mr. Santarella will be joined by two leading treaters of individuals with Alpha-1 Antitrypsin Deficiency.  Dr. Wells and Dr. Gupta will share their insights into the disease, it’s impacts and best practices to treat patients. This session is designed to have a fulsome understanding of Alpha-1 and the importance of diagnosis and treatment to improve the patient journey.

Moderator: Scott Santarella, CEO - Alpha-1 Foundation

Speakers: 
‍Dr. Nitika Arora Gupta, Professor of Pediatrics, Medical Director-Pediatric Hepatology and Live Transplant - Emory University School of Medicine Children's Healthcare of Atlanta

Mike Wells, M.D., MSPH, Associate Professor - University of Alabama at Birmingham (UAB)

11:45 - 12:45 PM 
Networking Lunch in Exhibit Hall 1 & 2 — Sponsored by ADMA Biologics
An opportunity for attendees to network with meeting participants, speakers, and sponsors.
‍
12:45 - 1:45 PM
SESSION 3: Election 2024: What to Expect from the 119th Congress and the Next Administration
On November 5, voters across the U.S. will head to the polls to elect the President, all 435 members of the US Congress, and one-third of the US Senate. How will the outcome affect the plasma industry?  Join former Congressman Kurt Schraeder (D-OR), Axios Health Correspondent Victoria Knight, and Republican strategist Alec Aramanda for a timely discussion of the election results and potential ramifications for our community.

Moderator: Sharon Pearce, Vice President, Lead of Government Affairs - PPTA

Speakers: 
Alec F. Aramanda, Principal - Williams & Jensen, PLLC

Hon. Kurt Schrader, Principal - Williams & Jensen, PLLC

Victoria Knight, Healthcare Reporter - Axios

1:45 - 2:45 PM
SESSION 4: VWD & PDTs: Patient and Physician Perspectives
In this session, patients and medical professionals come together to discuss the unique applications of plasma-derived therapies in von Willebrand disease,  which affects 1% of the U.S. population and is the most common bleeding disorder in the United States.This panel will feature both personal anecdotes and powerful experiences from patients, as well as medical information and advocacy from professionals. Don't miss it!

Moderator: Ilana Ostrin, Senior Director, Head of Global Communications - PPTA

Speakers:
Robert F. Sidonio, Jr., Associate Professor of Pediatrics - Emory University

Nikole Scappe-Hagen, Manager of Education - National Bleeding Disorders Foundation

Jennifer DeGlopper, VWD Patient Advocate

2:45 - 3:00 PM
Presentation of the Dr. Otto Schwarz Award

3:00 - 3:40 PM
Networking Break in the Exhibit Halls
An opportunity for attendees to network with meeting participants, speakers, and sponsors.

3:40 - 4:40 PM
SESSION 5: Patient Access in Canada
The Canadian Patient Advocacy panel will present the advocacy efforts of patient groups in Canada as they pursue better patient access to plasma-derived therapies. This panel will share their challenges and successes in improving patient outcomes in Canada.

Moderator: Bill Speir, Senior Director, Lead for North America Policy and Advocacy - PPTA

Speakers: 
Angela Diano, Executive Director - Alpha-1 Canada / AlphaNet
‍
Jennifer van Gennip, Executive Director - Network of Rare Bleeding Disorder Organizations

Donna Hartlen, Executive Director - GBS/CIDP Foundation of Canada

4:40 PM
Closure of Day One

4:40 - 6:30 PM
Networking Reception in Exhibit Hall 1 & 2 — Sponsored by ImmunoTek Bio Centers

TIME (Eastern)
07:30 AM
On-site registration open / Exhibit Halls Open (Breakfast available Exhibit Hall 1 & 2 — Sponsored by Abbott)
‍
8:30 - 9:15 AM
Day Two Kickoff and Welcome
‍
Welcoming Remarks
Joshua Penrod, Senior Vice President, Head of Global Plasma and Technical Advocacy - PPTA

Global Plasma Board of Directors Chairman's Message
Jerome Parnell III, Vice Chairman and Founder - ImmunoTek Bio Centers
‍
Keynote Speech
Michael P. Busch, M.D., Ph.D., Director/Professor - Vitalant Research Institute / UCSF

9:15 - 10:15 AM
SESSION 6: IG Patient Perspectives Panel
PPTA President and CEO Anita Brikman is joined by Lisa Butler, President and CEO of the GBS-CIDP Foundation, and Jorey Berry, President and CEO of the Immune Deficiency Foundation, for a unique look at the needs of patients who rely on immunoglobulins for their health and wellbeing. This panel will share unique insights from life changing foundations, inspiring patient stories, and motivation for partners to support patients and advocates in new ways.

Moderator: Anita Brikman, President & CEO - PPTA

Speakers: 
Lisa Butler, Executive Director - GBS|CIDP Foundation International

Jorey Berry, President & CEO - Immune Deficiency Foundation

10:15 - 10:30 AM
Patient Story
‍
Speaker: Corbin Whittington, President, Board of Directors - GBS/CIDP Foundation International
‍
10:30 - 10:45 AM
Networking Break in Exhibit Hall 1 & 2
An opportunity for attendees to network with meeting participants, speakers, and sponsors.
‍‍
10:45 AM - 12:00 PM
SESSION 7: Supply Chain Resilience: Policy Considerations and Business Landscape
This session will look at the evolution of regulations and policies related to supply chain resilience, including those introduced during the Covid-19 pandemic. In addition, it will describe current and future policy and regulatory considerations as they relate to management of potential supply disruptions and overall supply chain resilience, as well as how those considerations impact the business environment in our industry.

Moderator: Bob Wojcik - Takeda

Speakers:
‍
European Policy Perspective: Where are we going?
Stefaan Van der Spiegel (VIRTUAL), Head of Sector, DG Sante - European Commission

Regulatory and Policy Perspective in Supply Chain Resilience: Where are we going?
Ambassador Jayme White, Senior International Trade Advisor - Kelley Drye 

Business Landscape in an Evolving Supply Chain
Joe Malory, Senior Vice President, Commercial Operations - HemaSource

12:00 PM 
Closing Announcements & Boxed Lunches Available in Exhibit Hall 1 & 2